Papers
8,271
Jan 2024 โ€“ Aug 2026
2024 share
7.32%
of the month's papers, on average
2025 share
7.08%
of the month's papers, on average
2026 share
6.57%
of the month's papers, on average
Change
โ–ผ -10.2%
2024 โ†’ 2026, relative

Share of papers by month

Peak 8.4% in Oct 2024. Month-by-month values and sub-terms are on Keyword Trends.

Jan 2024Aug 2026

Dynamic thromboembolic risk

Several studies refine prediction of ischemic stroke and bleeding in atrial fibrillation. Recalculated CHA2DS2-VASc and HAS-BLED scores during six years of vitamin K antagonist treatment improved outcome assessment compared with baseline scores, while a landmarking model used time-dependent variables and Fine-Gray competing-risk methods to dynamically predict thromboembolism and bleeding in patients receiving direct oral anticoagulants (38460882; 41147381). In patients undergoing mitral valve transcatheter edge-to-edge repair, direct oral anticoagulants and vitamin K antagonists were compared using a composite of ischemic cerebrovascular and bleeding events (39895535).

๐Ÿ“„ Revista espanola de cardiologia (English ed.) โ†—๐Ÿ“„ Journal of the American Heart Association โ†—๐Ÿ“„ Journal of the American Heart Association โ†—

Stroke treatment and recovery

The stroke-focused papers evaluate secondary prevention, acute ischemic stroke treatment, and neurological recovery. An outpatient study assessed adherence to antihypertensives, antiplatelets, and statins after ischemic stroke, whereas a real-world study evaluated evolocumab on a background of statin therapy during the acute phase of ischemic stroke using lipid target attainment and major adverse cardiovascular events (38218048; 38063944). Mechanical thrombectomy was described in a vertebrobasilar occlusion case with bilateral sensorineural hearing loss, and deferoxamine was examined for early neurological improvement after intracerebral hemorrhage using serial NIH Stroke Scale measurements (39644154; 40418029).

๐Ÿ“„ Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association โ†—๐Ÿ“„ Journal of thrombosis and thrombolysis โ†—๐Ÿ“„ The neuroradiology journal โ†—๐Ÿ“„ International journal of stroke : official journal of the International Stroke Society โ†—

Heart failure risk and treatment

Heart-failure studies address prognosis, body size, treatment implementation, and therapeutic selection. In acute heart failure, beta-blocker use was evaluated in relation to NT-proBNP and mortality, while cohorts of patients eligible for cardiac resynchronization therapy and patients with acute HFpEF or HFrEF examined BMI in relation to mortality and other outcomes (39015043; 39031161; 40012479). The SwedeHF registry assessed use of renin-angiotensin system inhibitors or angiotensin receptor-neprilysin inhibitors, beta-blockers, mineralocorticoid receptor antagonists, and SGLT2 inhibitors during the first year after HFrEF diagnosis, and a cost-effectiveness analysis compared ACE inhibitors with ARBs (39783801; 39252272).

๐Ÿ“„ ESC heart failure โ†—๐Ÿ“„ ESC heart failure โ†—๐Ÿ“„ Minerva cardiology and angiology โ†—๐Ÿ“„ European journal of heart failure โ†—๐Ÿ“„ Medicine โ†—

Diabetes and atherosclerotic disease

These papers connect glycemic regulation, insulin resistance, lipid handling, and cardiovascular outcomes. In diabetic ApoE-deficient mice, liraglutide and ipragliflozin were tested separately and together for effects on atherosclerotic lesions, while a Hong Kong cohort examined whether initiating a DPP-4 inhibitor below versus above an HbA1c threshold affected HbA1c variability and major clinical events (38626913; 38802991). The ARIC analysis evaluated triglyceride-glucose-derived indices as predictors of cardiometabolic multimorbidity comprising diabetes, stroke, and coronary heart disease, and a prospective study assessed left-ventricular diastolic dysfunction in normotensive patients with type 2 diabetes (41468367; 40452345). In macrophage experiments, dapagliflozin combined with alirocumab reduced CD36-associated lipid-droplet formation and altered lipoprotein lipase activity more than either treatment alone (40990667).

๐Ÿ“„ Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association โ†—๐Ÿ“„ Diabetes, obesity & metabolism โ†—๐Ÿ“„ PloS one โ†—๐Ÿ“„ Annals of African medicine โ†—๐Ÿ“„ International journal of surgery (London, England) โ†—

Vascular biomarkers and imaging

Studies examined measures and models related to vascular injury, cardiovascular risk, and ischemic stroke. Aortic stiffness in the Rotterdam Study was analyzed as a predictor of coronary heart disease, stroke, cardiovascular disease, and mortality across age and sex groups, while post-COVID-19 research measured endothelial-colony forming cells and angiogenesis-related proteins at six and twelve months after infection (39196691; 38324145). A ceramide-based CER24 score was evaluated against the CERT1 score for predicting a composite outcome of all-cause mortality or nonfatal myocardial infarction in patients with suspected or known coronary artery disease (40685265). For acute ischemic stroke imaging, a symmetry-based segmentation method integrating 2.5D ResUNet and 3D nnUNet was developed to segment ischemic lesions on non-contrast CT scans (40908314).

๐Ÿ“„ Journal of hypertension โ†—๐Ÿ“„ Infection โ†—๐Ÿ“„ Nutrition, metabolism, and cardiovascular diseases : NMCD โ†—๐Ÿ“„ Clinical neuroradiology โ†—

Written by gpt-5.6-luna from 96 of this keyword's papers, a few from every whole month through Aug 2026; every paragraph was checked against the abstracts it cites. A paper counts for the keyword when its title, abstract, keywords or MeSH headings match the keyword's terms. Not medical advice; see the Disclaimer.